Zobrazeno 1 - 10
of 57
pro vyhledávání: '"MAKOTO NAKIRI"'
Autor:
Makoto Nakiri, Kosuke Ueda, Ryuji Hoshino, Naoki Ito, Hirofumi Kurose, Shoichiro Nohara, Koichiro Muraki, Chikayuki Hattori, Etsuyo Ogo, Tsukasa Igawa
Publikováno v:
IJU Case Reports, Vol 7, Iss 3, Pp 221-224 (2024)
Introduction The seeds used in brachytherapy for prostate cancer may migrate through the surrounding venous plexus to other sites in the body, most commonly to the pulmonary vasculature. Case presentation A 78‐year‐old Japanese man received iodin
Externí odkaz:
https://doaj.org/article/55e87c2c8f744d6b8e9d051b21528cc7
Autor:
Kosuke Ueda, Keiichiro Uemura, Naoki Ito, Yuya Sakai, Satoshi Ohnishi, Hiroki Suekane, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Sachiko Ogasawara, Hirohisa Yano, Tsukasa Igawa
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 1701-1712 (2024)
Immuno-oncology (IO) combination therapy is the first-line treatment for advanced renal cell carcinoma (RCC). However, biomarkers for predicting the response to IO combination therapy are lacking. Here, we investigated the association between the exp
Externí odkaz:
https://doaj.org/article/11f53d13330b4e1285ae6a5190539e9a
Autor:
Makoto Nakiri, Kosuke Ueda, Ryuji Hoshino, Naoyuki Ogasawara, Hirofumi Kurose, Kiyoaki Nishihara, Koichiro Muraki, Chikayuki Hattori, Etsuyo Ogo, Tsukasa Igawa
Publikováno v:
IJU Case Reports, Vol 6, Iss 3, Pp 169-172 (2023)
Introduction We describe a rare case of brachytherapy for prostate cancer in which a seed was lost from the perineum after a hydrogel injection. Case presentation A 71‐year‐old Japanese man was diagnosed with localized high‐risk prostate cancer
Externí odkaz:
https://doaj.org/article/18a16e8413d744949865938a95b4c01f
Autor:
Makoto Nakiri, Kosuke Ueda, Naoyuki Ogasawara, Hirofumi Kurose, Keiichiro Uemura, Kiyoaki Nishihara, Koichiro Muraki, Chikayuki Hattori, Etsuyo Ogo, Tsukasa Igawa
Publikováno v:
IJU Case Reports, Vol 5, Iss 4, Pp 223-226 (2022)
Introduction We present tri‐modality therapy with i‐125 brachytherapy for high‐risk prostate cancer after holmium laser enucleation of the prostate. Case presentation A 75‐year‐old man had visited our hospital with complaints of dysuria. Ho
Externí odkaz:
https://doaj.org/article/7d995e8092424a7cbb47a38feede0bbb
Autor:
Makoto Nakiri, Naoyuki Ogasawara, Hirofumi Kurose, Kosuke Ueda, Katsuaki Chikui, Kiyoaki Nishihara, Kazuhisa Ejima, Keiichiro Uemura, Kenta Murotani, Koichiro Muraki, Chikayuki Hattori, Etsuyo Ogo, Yoshitaka Morimatsu, Tatsuya Ishitake, Tsukasa Igawa
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 14, Iss 2, Pp 157-168 (2022)
Externí odkaz:
https://doaj.org/article/15782f7123944fda9ab40fe834136839
Autor:
Koichiro Muraki, Chikayuki Hattori, Etsuyo Ogo, Hiroaki Suefuji, Hidehiro Eto, Chiyoko Tsuji, Yusaku Miyata, Toshi Abe, Katsuaki Chikui, Makoto Nakiri, Tsukasa Igawa, Tatsuyuki Kakuma
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 3, Pp 254-262 (2021)
Externí odkaz:
https://doaj.org/article/4b01ac62a64341d39879ae27300b79fb
Autor:
Hirofumi Kurose, Kosuke Ueda, Mami Uegaki, Naoyuki Ogasawara, Hisaji Kumagae, Katsuaki Chikui, Makoto Nakiri, Kiyoaki Nishihara, Mitsunori Matsuo, Shigetaka Suekane, Jun Akiba, Hirohisa Yano, Tsukasa Igawa
Publikováno v:
IJU Case Reports, Vol 3, Iss 5, Pp 192-195 (2020)
Introduction Paraganglioma of the urinary bladder is a very rare disease accounting for 0.06% of all bladder tumors. Owing to their rarity and symptomatic variability, preoperative diagnosis is often difficult. Case presentation A 70‐year‐old mal
Externí odkaz:
https://doaj.org/article/9f8f7893d06b46e09f4bc91f9b015b0a
Autor:
Hirofumi Kurose, Kosuke Ueda, Makoto Nakiri, Mitsunori Matsuo, Shigetaka Suekane, Tsukasa Igawa
Publikováno v:
Urology Case Reports, Vol 33, Iss , Pp 101277- (2020)
Synchronous occurrence of triple primary cancers of urinary tract is quite rare and represents a difficult treatment challenge. Here, we report a case of a 78-year-old man with synchronous renal cell carcinoma, urothelial carcinoma of urinary bladder
Externí odkaz:
https://doaj.org/article/5e357cf3b8b545f19c80172def916097
Autor:
Hirofumi Kurose, Keisuke Komiya, Naoyuki Ogasawara, Kosuke Ueda, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Mitsunori Matsuo, Shigetaka Suekane, Tsukasa Igawa
Publikováno v:
LUTS: Lower Urinary Tract Symptoms. 15:89-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1357a8c753a2ef8439d45d61359b791
https://doi.org/10.1111/luts.12474
https://doi.org/10.1111/luts.12474
Autor:
Kosuke Ueda, Naoyuki Ogasawara, Naoki Ito, Satoshi Ohnishi, Hiroki Suekane, Hirofumi Kurose, Tasuku Hiroshige, Katsuaki Chikui, Keiichiro Uemura, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Tsukasa Igawa
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 6; Pages: 2417
Nivolumab and ipilimumab (NIVO + IPI) is standard therapy for patients with advanced renal cell carcinoma (RCC). Absolute lymphocyte count (ALC) is a valuable prognostic factor in patients with various cancers treated with immune checkpoint inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ca23fd28891f3b17dc6fe84fd7005f